Immuron Limited announced that the Therapeutic Goods Administration (TGA) has given GMP Clearance for Immuron?s packaging supplier allowing Travelan to be released for sale in Australia to retail pharmacy wholesalers and other customers. On July 5, 2023, Immuron announced fiscal year 2023 sales increase of 136% on fiscal year 2022 sales and at the same time advised that until the TGA provided GMP Clearance for a new packaging supplier, Travelan would be out of stock in wholesalers and pharmacies. If Immuron was able to supply product to wholesalers in June, fiscal year 2023 sales would have been even higher.

Immuron plans to release and dispatch Travelan to customers this week.